Rezultati pretrage - Alan L. Ho

Detaljiziraj rezultate
  1. 1
    The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent

    The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent od Jayasree S. Nair, Alan L. Ho, Gary K. Schwartz

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Regulation of Late G<sub>1</sub>/S Phase Transition and APC<sup>Cdh1</sup>by Reactive Oxygen Species

    Regulation of Late G<sub>1</sub>/S Phase Transition and APC<sup>Cdh1</sup>by Reactive Oxygen Species od Courtney G. Havens, Alan L. Ho, Naohisa Yoshioka, Steven F. Dowdy

    Izdano 2006
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy

    Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy od Robert M. Samstein, Alan L. Ho, Nancy Y. Lee, Christopher A. Barker

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Androgen Receptor Signaling in Salivary Gland Cancer

    Androgen Receptor Signaling in Salivary Gland Cancer od Martin G. Dalin, Philip A. Watson, Alan L. Ho, Luc G.T. Morris

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  5. 5
    Correlation of <i>BRAF</i><sup><i>V600E</i></sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study

    Correlation of <i>BRAF</i><sup><i>V600E</i></sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study od James Nagarajah, Alan L. Ho, R. Michael Tuttle, Wolfgang Weber, Ravinder K. Grewal

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death

    Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death od Grazia Ambrosini, Elgilda Musi, Alan L. Ho, Elisa de Stanchina, Gary K. Schwartz

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G<sub>1</sub> Cyclin-Dependent Kinase Complexes In Vivo

    Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G<sub>1</sub> Cyclin-Dependent Kinase Complexes In Vivo od Sergei A. Ezhevsky, Alan L. Ho, Michelle Becker‐Hapak, Penny K. Davis, Steven F. Dowdy

    Izdano 2001
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts

    Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts od Nora Katabi, Ronald Ghossein, Alan L. Ho, Snjezana Doğan, Lei Zhang, Yun‐Shao Sung, Cristina R. Antonescu

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype

    Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype od Alan L. Ho, Elgilda Musi, Grazia Ambrosini, Jayasree S. Nair, Shyamprasad Deraje Vasudeva, Elisa de Stanchina, Gary K. Schwartz

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780

    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780 od Jayasree S. Nair, Alan L. Ho, Archie Tse, Jesse Coward, Haider Cheema, Grazia Ambrosini, Nicholas Keen, Gary K. Schwartz

    Izdano 2009
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    PDGF Receptor Alpha Is an Alternative Mediator of Rapamycin-Induced Akt Activation: Implications for Combination Targeted Therapy of Synovial Sarcoma

    PDGF Receptor Alpha Is an Alternative Mediator of Rapamycin-Induced Akt Activation: Implications for Combination Targeted Therapy of Synovial Sarcoma od Alan L. Ho, Shyamprasad Deraje Vasudeva, Marick Laé, Tsuyoshi Saito, Violetta Barbashina, Cristina R. Antonescu, Marc Ladanyi, Gary K. Schwartz

    Izdano 2012
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    The evolving landscape of salivary gland tumors

    The evolving landscape of salivary gland tumors od Conor Steuer, Glenn J. Hanna, Kartik Viswanathan, James E. Bates, Azeem Kaka, Nicole C. Schmitt, Alan L. Ho, Nabil F. Saba

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  13. 13
    Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands

    Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands od Bin Xu, Esther Drill, Allen S. Ho, Alan L. Ho, Lara Dunn, Carlos Nicolas Prieto-Granada, Timothy A. Chan, Ian Ganly, Ronald Ghossein, Nora Katabi

    Izdano 2017
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    The immune microenvironment and expression of PD‐L1, PD‐1, PRAME and MHC I in salivary duct carcinoma

    The immune microenvironment and expression of PD‐L1, PD‐1, PRAME and MHC I in salivary duct carcinoma od Bin Xu, Achim A. Jungbluth, Denise Frosina, Bayan Alzumaili, Nathaniel Aleynick, Elzbieta Slodkowska, Kevin Higgins, Alan L. Ho, Luc G.T. Morris, Ronald Ghossein, Nora Katabi

    Izdano 2019
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

    Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma od Vatche Tchekmedyian, Eric J. Sherman, Lara Dunn, Crystal Tran, Shrujal S. Baxi, Nora Katabi, Cristina R. Antonescu, Irina Ostrovnaya, Sofia Haque, David G. Pfister, Alan L. Ho

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

    A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSC... od Lara Dunn, Matthew G. Fury, Han Xiao, Shrujal S. Baxi, Eric J. Sherman, Susan Korte, Christian Pfister, Sofia Haque, Nora Katabi, Alan L. Ho, David G. Pfister

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer

    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer od Eric J. Sherman, Lara Dunn, Alan L. Ho, Shrujal S. Baxi, Ronald Ghossein, Matthew G. Fury, Sofia Haque, Cami S. Sima, Grace Cullen, James A. Fagin, David G. Pfister

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Distant metastasis of salivary gland cancer: Incidence, management, and outcomes

    Distant metastasis of salivary gland cancer: Incidence, management, and outcomes od Ximena Mimica, Marlena McGill, Ashley Hay, Daniella K. Zanoni, Jatin P. Shah, Richard J. Wong, Alan L. Ho, Marc A. Cohen, Snehal G. Patel, Ian Ganly

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma

    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma od Johanna C. Bendell, Valérie André, Alan L. Ho, Ragini R. Kudchadkar, Michael R. Migden, Jeffrey R. Infante, Ramón V. Tiu, Celine Pitou, Trevor Tucker, Les Brail, Daniel D. Von Hoff

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers

    Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers od Brian R. Untch, Vanessa Dos Anjos, María E.R. García-Rendueles, Jeffrey A. Knauf, Gnana P. Krishnamoorthy, Mahesh Saqcena, Umesh Bhanot, Nicholas D. Socci, Alan L. Ho, Ronald Ghossein, James A. Fagin

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: